In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges

被引:180
作者
Mout, Rubul [1 ]
Ray, Moumita [1 ]
Lee, Yi-Wei [1 ]
Scaletti, Federica [1 ]
Rotello, Vincent M. [1 ]
机构
[1] Univ Massachusetts, Dept Chem, 710 North Pleasant St, Amherst, MA 01003 USA
关键词
MUSCULAR-DYSTROPHY; MEDIATED DELIVERY; MOUSE MODEL; HUMAN-CELLS; GENOME; CAS9; RNA; CRISPR-CAS9; NUCLEASES; ENDONUCLEASE;
D O I
10.1021/acs.bioconjchem.7b00057
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The successful use of clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9-based gene editing for therapeutics requires efficient in vivo delivery of the CRISPR components. There are, however, major challenges on the delivery front. In this Topical Review, we will highlight recent developments in CRISPR delivery, and we will present hurdles that still need to be overcome to achieve effective in vivo editing.
引用
收藏
页码:880 / 884
页数:5
相关论文
共 39 条
[21]   RNA-Guided Human Genome Engineering via Cas9 [J].
Mali, Prashant ;
Yang, Luhan ;
Esvelt, Kevin M. ;
Aach, John ;
Guell, Marc ;
DiCarlo, James E. ;
Norville, Julie E. ;
Church, George M. .
SCIENCE, 2013, 339 (6121) :823-826
[22]  
Mout R., 2017, ACS NANO, DOI [10.1021/acsnano.6b07600, DOI 10.1021/ACSNAN0.6B07600]
[23]   Towards a systems understanding of MHC class I and MHC class II antigen presentation [J].
Neefjes, Jacques ;
Jongsma, Marlieke L. M. ;
Paul, Petra ;
Bakke, Oddmund .
NATURE REVIEWS IMMUNOLOGY, 2011, 11 (12) :823-836
[24]   Engineering Delivery Vehicles for Genome Editing [J].
Nelson, Christopher E. ;
Gersbach, Charles A. .
ANNUAL REVIEW OF CHEMICAL AND BIOMOLECULAR ENGINEERING, VOL 7, 2016, 7 :637-662
[25]   In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy [J].
Nelson, Christopher E. ;
Hakim, Chady H. ;
Ousterout, David G. ;
Thakore, Pratiksha I. ;
Moreb, Eirik A. ;
Rivera, Ruth M. Castellanos ;
Madhavan, Sarina ;
Pan, Xiufang ;
Ran, F. Ann ;
Yan, Winston X. ;
Asokan, Aravind ;
Zhang, Feng ;
Duan, Dongsheng ;
Gersbach, Charles A. .
SCIENCE, 2016, 351 (6271) :403-407
[26]   Nanocarriers as an emerging platform for cancer therapy [J].
Peer, Dan ;
Karp, Jeffrey M. ;
Hong, SeungPyo ;
FaroKHzad, Omid C. ;
Margalit, Rimona ;
Langer, Robert .
NATURE NANOTECHNOLOGY, 2007, 2 (12) :751-760
[27]   Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA [J].
Ramakrishna, Suresh ;
Dad, Abu-Bonsrah Kwaku ;
Beloor, Jagadish ;
Gopalappa, Ramu ;
Lee, Sang-Kyung ;
Kim, Hyongbum .
GENOME RESEARCH, 2014, 24 (06) :1020-1027
[28]   In vivo genome editing using Staphylococcus aureus Cas9 [J].
Ran, F. Ann ;
Cong, Le ;
Yan, Winston X. ;
Scott, David A. ;
Gootenberg, Jonathan S. ;
Kriz, Andrea J. ;
Zetsche, Bernd ;
Shalem, Ophir ;
Wu, Xuebing ;
Makarova, Kira S. ;
Koonin, Eugene V. ;
Sharp, Phillip A. ;
Zhang, Feng .
NATURE, 2015, 520 (7546) :186-U98
[29]   CRISPR-Cas systems for editing, regulating and targeting genomes [J].
Sander, Jeffry D. ;
Joung, J. Keith .
NATURE BIOTECHNOLOGY, 2014, 32 (04) :347-355
[30]   CRISPR/Cas9-mediated genome engineering: An adeno-associated viral (AAV) vector toolbox [J].
Senis, Elena ;
Fatouros, Chronis ;
Grosse, Stefanie ;
Wiedtke, Ellen ;
Niopek, Dominik ;
Mueller, Ann-Kristin ;
Boerner, Kathleen ;
Grimm, Dirk .
BIOTECHNOLOGY JOURNAL, 2014, 9 (11) :1402-1412